Vadim Shevyrin
Overview
Explore the profile of Vadim Shevyrin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demicheva E, Polanco Espino F, Vedeneev P, Shevyrin V, Buhler A, Mukhlynina E, et al.
Metabolites
. 2025 Jan;
15(1).
PMID: 39852402
Immunodeficiency conditions, which are characterized by reduced immune activity that promotes the development of chronic diseases, are needed for efficient monitoring. A promising area of monitoring and early diagnosis of...
2.
Demicheva E, Dordiuk V, Polanco Espino F, Ushenin K, Aboushanab S, Shevyrin V, et al.
Metabolites
. 2024 Jan;
14(1).
PMID: 38248857
Blood metabolomics profiling using mass spectrometry has emerged as a powerful approach for investigating non-cancer diseases and understanding their underlying metabolic alterations. Blood, as a readily accessible physiological fluid, contains...
3.
Kavanagh P, Gofenberg M, Shevyrin V, Dvorskaya O, Dowling G, Grigoryev A
Drug Test Anal
. 2020 Jul;
12(10):1442-1451.
PMID: 32621389
Cathinone derivatives are one of the more prominent groups of new psychoactive substances in terms of the number of forensic case reports and the variety of chemical structures available. These...
4.
Volgin A, Yang L, Amstislavskaya T, Demin K, Wang D, Yan D, et al.
ACS Chem Neurosci
. 2020 Jan;
PMID: 31904216
Kava (kava kava, ) is a common drug-containing plant in the Pacific islands. Kavalactones, its psychoactive compounds, exert potent central nervous system (CNS) action clinically and in animal models. However,...
5.
Shevyrin V, Eltsov O, Shafran Y
Drug Test Anal
. 2019 Nov;
12(1):159-163.
PMID: 31667946
No abstract available.
6.
Grigoryev A, Kavanagh P, Labutin A, Pechnikov A, Dowling G, Shevyrin V, et al.
Drug Test Anal
. 2019 Jun;
11(9):1387-1402.
PMID: 31243890
Synthetic cannabinoids (SCs), mimicking the psychoactive effects of cannabis, consist of a vast array of structurally diverse compounds. A novel compound belonging to the SC family, (1-(cyclohexylmethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone (named TMCP-CHM in...
7.
Shevyrin V, Shafran Y
J Mass Spectrom
. 2017 Jul;
52(10):633-637.
PMID: 28708288
Differentiation of new psychoactive substance (NPS), 6-(2-methylaminopropyl)benzofuran (6-MAPB), and its positional isomer, 2-(2-methylaminopropyl)benzofuran (2-MAPB), by means of gas chromatography/mass spectrometry (GC/MS) with quadrupole detection is ambiguous. Reliable distinguishing of the...
8.
Shevyrin V, Kupriyanova O, Lebedev A, Melkozerov V, Eltsov O, Shafran Y, et al.
J Mass Spectrom
. 2016 Jul;
51(10):969-979.
PMID: 27388323
Emergence of new psychoactive substances, hallucinogenic phenethylamines in particular, in illicit market is a serious threat to human health in global scale. We have detected and identified N-(2-methoxybenzyl)-2-(2,4,6-trimethoxyphenyl)ethanamine (2,4,6-TMPEA-NBOMe), a...
9.
Shevyrin V, Melkozerov V, Eltsov O, Shafran Y, Morzherin Y
Forensic Sci Int
. 2016 Jan;
259:95-100.
PMID: 26771874
We were the first to detect 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole (given name BzODZ-EPyr) as a new synthetic cannabinoid, in illegal market of new psychoactive compounds (NPS). The compound was known only from pharmaceutical...
10.
Shevyrin V, Melkozerov V, Nevero A, Eltsov O, Shafran Y, Morzherin Y, et al.
Anal Bioanal Chem
. 2015 Apr;
407(21):6301-15.
PMID: 25893797
Illicit new psychoactive substances (NPS) are a serious threat to health throughout the world. Such NPS do not usually pass preliminary pharmacological trials. In 2014, we identified a series of...